期刊
PROTEOMICS CLINICAL APPLICATIONS
卷 2, 期 10-11, 页码 1403-1412出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.200780173
关键词
Biomarkers; 2-D DIGE; 2-D PAGE; Mass spectrometry; Quantitative proteomics
资金
- National Cancer Institute, National Institutes of Health [NO1-CO-12400]
While many of the developments made in high-throughput proteomics were originally applied to procaryotic and simple eucaryotic organisms, the analysis of biofluids became increasingly important as the prospect of using proteomics to discover novel biomarkers became realized. Biofluids have represented a unique challenge to proteomics as they are often present only in small amounts and, particularly in the cases of serum and plasma, can have protein concentration ranges that differ by ten orders of magnitude. While the discovery of authentic, clinically useful biomarkers in the proteomics era has been lacking, there have been a number of significant developments in the ability to more comprehensively characterize biofluid proteomes. The rapid pace of these developments suggest that the eventual discovery of clinically validate biomarkers using proteomic technologies still has a bright future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据